Infected Blood Compensation Scheme

Charlotte Nichols Excerpts

Tuesday 14th April 2026 Commons Chamber

[Nick Thomas-Symonds]

I thank the shadow Minister for the tone that he took in that response and for the supportive tone that he has taken throughout. I will pick up on some of his earlier points. I agree with him entirely when he talks of the heinous nature of the medical experimentation on children that happened during this scandal. Although I have increased the specific amounts, it should be pointed out that those amounts do not stand in isolation; they are specific amounts for the particularly egregious nature of what happened, which are within much higher settlements, and that is exactly as it should be.

On the point about the inquiry, yes, there has now been the formal exchange of letters between me as the responsible Minister and Sir Brian Langstaff. Also, I entirely agree with the shadow Minister about the need for policy certainty going forward. He asked some very reasonable, detailed questions, and I will come back to him properly in writing on those, but let me just deal with a few of them.

I want to bring forward further legislation as soon as possible. When I have brought forward legislation in the past, parties across the House have always worked in a collaborative way throughout to get it through as quickly as possible. Obviously, positions are a matter for the Opposition parties, but continuing that constructive spirit is helpful in getting these things through as quickly as possible.

On the issue of exceptional loss, again, that £60,000, as referred to by the shadow Minister, is not designed to be a very detailed, individualised assessment. That is not what a tariff-based scheme is meant to do. Rather, it is meant to look at the situation of loss of a chance—the situation where somebody, but for their infection or how they were affected by the infection, would have had the opportunity to have gone on and perhaps been a higher-than-average earner but were denied that—and is designed specifically to look at that. On the other very reasonable and detailed matters that the hon. Gentleman raises, I will ensure he gets a full written response.

[Charlotte Nichols (Warrington North) (Lab)]

Does the Minister accept that although people co-infected with HIV and hepatitis C represent only around 7% of those on infected blood support schemes, they make up roughly 14% of those receiving special category support, because of the disproportionate harm caused by early hepatitis C treatments? Does he believe that today’s announcement properly recognises their suffering?

[Nick Thomas-Symonds]

Whether it is in relation to the co-infected, to whom my hon. Friend so movingly refers, or other people who are both infected and affected by this scandal, the compensation scheme seeks to recognise everything—all the harms that have happened to them and how they have suffered. I will just say, though, that this was always meant to be a tariff-based scheme—it is meant to produce broad justice—and part of the reason for that is to try to prevent those highly individualised searches for evidence which, frankly, with this distance of time, would simply not be possible.